The worldwide epidemic of diabetic retinopathy

Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic re...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Yingfeng Zheng [verfasserIn] Mingguang He [verfasserIn] Nathan Congdon [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2012

Schlagwörter:	Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services

Übergeordnetes Werk:	In: Indian Journal of Ophthalmology - Wolters Kluwer Medknow Publications, 2005, 60(2012), 5, Seite 428-431
Übergeordnetes Werk:	volume:60 ; year:2012 ; number:5 ; pages:428-431

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.4103/0301-4738.100542

Katalog-ID:	DOAJ031296688

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ031296688
003	DE-627
005	20230503152213.0
007	cr uuu---uuuuu
008	230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.4103/0301-4738.100542 \|2 doi
035			\|a (DE-627)DOAJ031296688
035			\|a (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RE1-994
100	0		\|a Yingfeng Zheng \|e verfasserin \|4 aut
245	1	4	\|a The worldwide epidemic of diabetic retinopathy
264		1	\|c 2012
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.
650		4	\|a Diabetes-related blindness
650		4	\|a diabetic retinopathy
650		4	\|a key informant
650		4	\|a rapid assessment of avoidable blindness
650		4	\|a retinopathy of prematurity
650		4	\|a tele-ophthalmology
650		4	\|a Blindness
650		4	\|a disability
650		4	\|a equity
650		4	\|a health economics
650		4	\|a health policy
650		4	\|a health and development
650		4	\|a social exclusion
650		4	\|a Community eye health
650		4	\|a prevention of blindness
650		4	\|a ophthalmogical residency
650		4	\|a VISION 2020
650		4	\|a Visual impairment
650		4	\|a blindness
650		4	\|a inequality
650		4	\|a social class
650		4	\|a income
650		4	\|a educational status
650		4	\|a gender and ethnic groups
650		4	\|a Advocacy
650		4	\|a effective service delivery
650		4	\|a enabling environment
650		4	\|a stakeholders
650		4	\|a resources
650		4	\|a Avoidable blindness and visual impairment
650		4	\|a impact
650		4	\|a scaling up
650		4	\|a Global blindness
650		4	\|a prevalence
650		4	\|a visual impairment
650		4	\|a visual acuity
650		4	\|a Comprehensive eye care
650		4	\|a eye care model
650		4	\|a pyramidal model
650		4	\|a optometrist
650		4	\|a optometry regulation
650		4	\|a eye health
650		4	\|a India
650		4	\|a Economics
650		4	\|a market
650		4	\|a government
650		4	\|a cost
650		4	\|a Millennium development goals
650		4	\|a Vision 2020 the Right to Sight
650		4	\|a eye care services
650		4	\|a planning rapid assessment methods
650		4	\|a Avoidable blindness
650		4	\|a cataract surgical rate
650		4	\|a corneal blindness
650		4	\|a Compliance
650		4	\|a services
653		0	\|a Ophthalmology
700	0		\|a Mingguang He \|e verfasserin \|4 aut
700	0		\|a Nathan Congdon \|e verfasserin \|4 aut
773	0	8	\|i In \|t Indian Journal of Ophthalmology \|d Wolters Kluwer Medknow Publications, 2005 \|g 60(2012), 5, Seite 428-431 \|w (DE-627)485243563 \|w (DE-600)2185999-1 \|x 19983689 \|7 nnns
773	1	8	\|g volume:60 \|g year:2012 \|g number:5 \|g pages:428-431
856	4	0	\|u https://doi.org/10.4103/0301-4738.100542 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 \|z kostenfrei
856	4	0	\|u http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/0301-4738 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1998-3689 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2050
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 60 \|j 2012 \|e 5 \|h 428-431

Indexfelder

author_variant	y z yz m h mh n c nc
matchkey_str	article:19983689:2012----::hwrdiepdmcfibtc
hierarchy_sort_str	2012
callnumber-subject-code	RE
publishDate	2012
allfields	10.4103/0301-4738.100542 doi (DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7 DE-627 ger DE-627 rakwb eng RE1-994 Yingfeng Zheng verfasserin aut The worldwide epidemic of diabetic retinopathy 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR. Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology Mingguang He verfasserin aut Nathan Congdon verfasserin aut In Indian Journal of Ophthalmology Wolters Kluwer Medknow Publications, 2005 60(2012), 5, Seite 428-431 (DE-627)485243563 (DE-600)2185999-1 19983689 nnns volume:60 year:2012 number:5 pages:428-431 https://doi.org/10.4103/0301-4738.100542 kostenfrei https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 kostenfrei http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng kostenfrei https://doaj.org/toc/0301-4738 Journal toc kostenfrei https://doaj.org/toc/1998-3689 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 60 2012 5 428-431
spelling	10.4103/0301-4738.100542 doi (DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7 DE-627 ger DE-627 rakwb eng RE1-994 Yingfeng Zheng verfasserin aut The worldwide epidemic of diabetic retinopathy 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR. Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology Mingguang He verfasserin aut Nathan Congdon verfasserin aut In Indian Journal of Ophthalmology Wolters Kluwer Medknow Publications, 2005 60(2012), 5, Seite 428-431 (DE-627)485243563 (DE-600)2185999-1 19983689 nnns volume:60 year:2012 number:5 pages:428-431 https://doi.org/10.4103/0301-4738.100542 kostenfrei https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 kostenfrei http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng kostenfrei https://doaj.org/toc/0301-4738 Journal toc kostenfrei https://doaj.org/toc/1998-3689 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 60 2012 5 428-431
allfields_unstemmed	10.4103/0301-4738.100542 doi (DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7 DE-627 ger DE-627 rakwb eng RE1-994 Yingfeng Zheng verfasserin aut The worldwide epidemic of diabetic retinopathy 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR. Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology Mingguang He verfasserin aut Nathan Congdon verfasserin aut In Indian Journal of Ophthalmology Wolters Kluwer Medknow Publications, 2005 60(2012), 5, Seite 428-431 (DE-627)485243563 (DE-600)2185999-1 19983689 nnns volume:60 year:2012 number:5 pages:428-431 https://doi.org/10.4103/0301-4738.100542 kostenfrei https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 kostenfrei http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng kostenfrei https://doaj.org/toc/0301-4738 Journal toc kostenfrei https://doaj.org/toc/1998-3689 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 60 2012 5 428-431
allfieldsGer	10.4103/0301-4738.100542 doi (DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7 DE-627 ger DE-627 rakwb eng RE1-994 Yingfeng Zheng verfasserin aut The worldwide epidemic of diabetic retinopathy 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR. Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology Mingguang He verfasserin aut Nathan Congdon verfasserin aut In Indian Journal of Ophthalmology Wolters Kluwer Medknow Publications, 2005 60(2012), 5, Seite 428-431 (DE-627)485243563 (DE-600)2185999-1 19983689 nnns volume:60 year:2012 number:5 pages:428-431 https://doi.org/10.4103/0301-4738.100542 kostenfrei https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 kostenfrei http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng kostenfrei https://doaj.org/toc/0301-4738 Journal toc kostenfrei https://doaj.org/toc/1998-3689 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 60 2012 5 428-431
allfieldsSound	10.4103/0301-4738.100542 doi (DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7 DE-627 ger DE-627 rakwb eng RE1-994 Yingfeng Zheng verfasserin aut The worldwide epidemic of diabetic retinopathy 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR. Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology Mingguang He verfasserin aut Nathan Congdon verfasserin aut In Indian Journal of Ophthalmology Wolters Kluwer Medknow Publications, 2005 60(2012), 5, Seite 428-431 (DE-627)485243563 (DE-600)2185999-1 19983689 nnns volume:60 year:2012 number:5 pages:428-431 https://doi.org/10.4103/0301-4738.100542 kostenfrei https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 kostenfrei http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng kostenfrei https://doaj.org/toc/0301-4738 Journal toc kostenfrei https://doaj.org/toc/1998-3689 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 60 2012 5 428-431
language	English
source	In Indian Journal of Ophthalmology 60(2012), 5, Seite 428-431 volume:60 year:2012 number:5 pages:428-431
sourceStr	In Indian Journal of Ophthalmology 60(2012), 5, Seite 428-431 volume:60 year:2012 number:5 pages:428-431
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services Ophthalmology
isfreeaccess_bool	true
container_title	Indian Journal of Ophthalmology
authorswithroles_txt_mv	Yingfeng Zheng @@aut@@ Mingguang He @@aut@@ Nathan Congdon @@aut@@
publishDateDaySort_date	2012-01-01T00:00:00Z
hierarchy_top_id	485243563
id	DOAJ031296688
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ031296688</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503152213.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4103/0301-4738.100542</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ031296688</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yingfeng Zheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The worldwide epidemic of diabetic retinopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes-related blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetic retinopathy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">key informant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rapid assessment of avoidable blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinopathy of prematurity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tele-ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">disability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">equity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health and development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">social exclusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Community eye health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevention of blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ophthalmogical residency</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VISION 2020</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">inequality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">social class</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">income</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">educational status</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gender and ethnic groups</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Advocacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">effective service delivery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">enabling environment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">stakeholders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resources</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Avoidable blindness and visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">impact</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">scaling up</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Global blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevalence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual acuity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Comprehensive eye care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye care model</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pyramidal model</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">optometrist</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">optometry regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">India</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">market</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">government</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cost</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Millennium development goals</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vision 2020 the Right to Sight</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye care services</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">planning rapid assessment methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Avoidable blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cataract surgical rate</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">corneal blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Compliance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">services</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mingguang He</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nathan Congdon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Indian Journal of Ophthalmology</subfield><subfield code="d">Wolters Kluwer Medknow Publications, 2005</subfield><subfield code="g">60(2012), 5, Seite 428-431</subfield><subfield code="w">(DE-627)485243563</subfield><subfield code="w">(DE-600)2185999-1</subfield><subfield code="x">19983689</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:428-431</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4103/0301-4738.100542</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0301-4738</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1998-3689</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2057</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2012</subfield><subfield code="e">5</subfield><subfield code="h">428-431</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Yingfeng Zheng
spellingShingle	Yingfeng Zheng misc RE1-994 misc Diabetes-related blindness misc diabetic retinopathy misc key informant misc rapid assessment of avoidable blindness misc retinopathy of prematurity misc tele-ophthalmology misc Blindness misc disability misc equity misc health economics misc health policy misc health and development misc social exclusion misc Community eye health misc prevention of blindness misc ophthalmogical residency misc VISION 2020 misc Visual impairment misc blindness misc inequality misc social class misc income misc educational status misc gender and ethnic groups misc Advocacy misc effective service delivery misc enabling environment misc stakeholders misc resources misc Avoidable blindness and visual impairment misc impact misc scaling up misc Global blindness misc prevalence misc visual impairment misc visual acuity misc Comprehensive eye care misc eye care model misc pyramidal model misc optometrist misc optometry regulation misc eye health misc India misc Economics misc market misc government misc cost misc Millennium development goals misc Vision 2020 the Right to Sight misc eye care services misc planning rapid assessment methods misc Avoidable blindness misc cataract surgical rate misc corneal blindness misc Compliance misc services misc Ophthalmology The worldwide epidemic of diabetic retinopathy
authorStr	Yingfeng Zheng
ppnlink_with_tag_str_mv	@@773@@(DE-627)485243563
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RE1-994
illustrated	Not Illustrated
issn	19983689
topic_title	RE1-994 The worldwide epidemic of diabetic retinopathy Diabetes-related blindness diabetic retinopathy key informant rapid assessment of avoidable blindness retinopathy of prematurity tele-ophthalmology Blindness disability equity health economics health policy health and development social exclusion Community eye health prevention of blindness ophthalmogical residency VISION 2020 Visual impairment blindness inequality social class income educational status gender and ethnic groups Advocacy effective service delivery enabling environment stakeholders resources Avoidable blindness and visual impairment impact scaling up Global blindness prevalence visual impairment visual acuity Comprehensive eye care eye care model pyramidal model optometrist optometry regulation eye health India Economics market government cost Millennium development goals Vision 2020 the Right to Sight eye care services planning rapid assessment methods Avoidable blindness cataract surgical rate corneal blindness Compliance services
topic	misc RE1-994 misc Diabetes-related blindness misc diabetic retinopathy misc key informant misc rapid assessment of avoidable blindness misc retinopathy of prematurity misc tele-ophthalmology misc Blindness misc disability misc equity misc health economics misc health policy misc health and development misc social exclusion misc Community eye health misc prevention of blindness misc ophthalmogical residency misc VISION 2020 misc Visual impairment misc blindness misc inequality misc social class misc income misc educational status misc gender and ethnic groups misc Advocacy misc effective service delivery misc enabling environment misc stakeholders misc resources misc Avoidable blindness and visual impairment misc impact misc scaling up misc Global blindness misc prevalence misc visual impairment misc visual acuity misc Comprehensive eye care misc eye care model misc pyramidal model misc optometrist misc optometry regulation misc eye health misc India misc Economics misc market misc government misc cost misc Millennium development goals misc Vision 2020 the Right to Sight misc eye care services misc planning rapid assessment methods misc Avoidable blindness misc cataract surgical rate misc corneal blindness misc Compliance misc services misc Ophthalmology
topic_unstemmed	misc RE1-994 misc Diabetes-related blindness misc diabetic retinopathy misc key informant misc rapid assessment of avoidable blindness misc retinopathy of prematurity misc tele-ophthalmology misc Blindness misc disability misc equity misc health economics misc health policy misc health and development misc social exclusion misc Community eye health misc prevention of blindness misc ophthalmogical residency misc VISION 2020 misc Visual impairment misc blindness misc inequality misc social class misc income misc educational status misc gender and ethnic groups misc Advocacy misc effective service delivery misc enabling environment misc stakeholders misc resources misc Avoidable blindness and visual impairment misc impact misc scaling up misc Global blindness misc prevalence misc visual impairment misc visual acuity misc Comprehensive eye care misc eye care model misc pyramidal model misc optometrist misc optometry regulation misc eye health misc India misc Economics misc market misc government misc cost misc Millennium development goals misc Vision 2020 the Right to Sight misc eye care services misc planning rapid assessment methods misc Avoidable blindness misc cataract surgical rate misc corneal blindness misc Compliance misc services misc Ophthalmology
topic_browse	misc RE1-994 misc Diabetes-related blindness misc diabetic retinopathy misc key informant misc rapid assessment of avoidable blindness misc retinopathy of prematurity misc tele-ophthalmology misc Blindness misc disability misc equity misc health economics misc health policy misc health and development misc social exclusion misc Community eye health misc prevention of blindness misc ophthalmogical residency misc VISION 2020 misc Visual impairment misc blindness misc inequality misc social class misc income misc educational status misc gender and ethnic groups misc Advocacy misc effective service delivery misc enabling environment misc stakeholders misc resources misc Avoidable blindness and visual impairment misc impact misc scaling up misc Global blindness misc prevalence misc visual impairment misc visual acuity misc Comprehensive eye care misc eye care model misc pyramidal model misc optometrist misc optometry regulation misc eye health misc India misc Economics misc market misc government misc cost misc Millennium development goals misc Vision 2020 the Right to Sight misc eye care services misc planning rapid assessment methods misc Avoidable blindness misc cataract surgical rate misc corneal blindness misc Compliance misc services misc Ophthalmology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Indian Journal of Ophthalmology
hierarchy_parent_id	485243563
hierarchy_top_title	Indian Journal of Ophthalmology
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)485243563 (DE-600)2185999-1
title	The worldwide epidemic of diabetic retinopathy
ctrlnum	(DE-627)DOAJ031296688 (DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7
title_full	The worldwide epidemic of diabetic retinopathy
author_sort	Yingfeng Zheng
journal	Indian Journal of Ophthalmology
journalStr	Indian Journal of Ophthalmology
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2012
contenttype_str_mv	txt
container_start_page	428
author_browse	Yingfeng Zheng Mingguang He Nathan Congdon
container_volume	60
class	RE1-994
format_se	Elektronische Aufsätze
author-letter	Yingfeng Zheng
doi_str_mv	10.4103/0301-4738.100542
author2-role	verfasserin
title_sort	worldwide epidemic of diabetic retinopathy
callnumber	RE1-994
title_auth	The worldwide epidemic of diabetic retinopathy
abstract	Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.
abstractGer	Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.
abstract_unstemmed	Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2031 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2061 GBV_ILN_2111 GBV_ILN_2113 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	5
title_short	The worldwide epidemic of diabetic retinopathy
url	https://doi.org/10.4103/0301-4738.100542 https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7 http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng https://doaj.org/toc/0301-4738 https://doaj.org/toc/1998-3689
remote_bool	true
author2	Mingguang He Nathan Congdon
author2Str	Mingguang He Nathan Congdon
ppnlink	485243563
callnumber-subject	RE - Ophthalmology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.4103/0301-4738.100542
callnumber-a	RE1-994
up_date	2024-07-03T19:49:42.382Z
_version_	1803588659983679488
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ031296688</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503152213.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4103/0301-4738.100542</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ031296688</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJab45c75d8eea46a8bfcb9a270a41bbf7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Yingfeng Zheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The worldwide epidemic of diabetic retinopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world′s health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes-related blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetic retinopathy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">key informant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rapid assessment of avoidable blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinopathy of prematurity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tele-ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">disability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">equity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health and development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">social exclusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Community eye health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevention of blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ophthalmogical residency</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VISION 2020</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">inequality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">social class</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">income</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">educational status</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gender and ethnic groups</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Advocacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">effective service delivery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">enabling environment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">stakeholders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resources</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Avoidable blindness and visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">impact</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">scaling up</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Global blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevalence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual impairment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual acuity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Comprehensive eye care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye care model</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pyramidal model</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">optometrist</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">optometry regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">India</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">market</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">government</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cost</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Millennium development goals</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vision 2020 the Right to Sight</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eye care services</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">planning rapid assessment methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Avoidable blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cataract surgical rate</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">corneal blindness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Compliance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">services</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mingguang He</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nathan Congdon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Indian Journal of Ophthalmology</subfield><subfield code="d">Wolters Kluwer Medknow Publications, 2005</subfield><subfield code="g">60(2012), 5, Seite 428-431</subfield><subfield code="w">(DE-627)485243563</subfield><subfield code="w">(DE-600)2185999-1</subfield><subfield code="x">19983689</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:428-431</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4103/0301-4738.100542</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ab45c75d8eea46a8bfcb9a270a41bbf7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=5;spage=428;epage=431;aulast=Zheng</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0301-4738</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1998-3689</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2057</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2012</subfield><subfield code="e">5</subfield><subfield code="h">428-431</subfield></datafield></record></collection>
score	7.4024982

Nicht das Richtige dabei?

Schreiben Sie uns!

The worldwide epidemic of diabetic retinopathy

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?